Literature DB >> 15741546

A recombinant cysteine proteinase from Leishmania (Leishmania) chagasi suitable for serodiagnosis of American visceral leishmaniasis.

Suzana de Souza Dias1, Paulo Henrique da Costa Pinheiro, Simone Katz, Márcia Regina Machado dos Santos, Clara Lúcia Barbiéri.   

Abstract

A recombinant protein, rLdccys1, which was produced by expression of the gene encoding a 30 kDa cysteine proteinase from Leishmania (Leishmania) chagasi, was used for detection of antibodies in sera from patients with active visceral leishmaniasis (VL) in enzyme-linked immunosorbent assays. Analysis of the predicted amino acid sequence of rLdccys1 showed that it contains all the characteristics of a cysteine proteinase. The ability of the protein to react with sera from humans with VL was also shown by Western blotting. The sensitivity for detection of specific antibodies to L. (L.) chagasi bodies using rLdccys1, L. (L.) chagasi promastigote lysates, and amastigote lysates was 80%, 98%, and 99%, respectively. No cross-reactivity between rLdccys1 and Chagas disease was observed, and there was little positive reactivity with sera from patients with cutaneous leishmaniasis and tuberculosis, compared with promastigote and amastigote extracts. Our findings indicate that rLdccys1 from L. (L.) chagasi constitutes a potential tool for the diagnosis of American VL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741546

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Serological characterizations of tandem repeat proteins for detection of African trypanosome infection in cattle.

Authors:  Yasuyuki Goto; Malcolm S Duthie; Thu-Thuy Nguyen; Masahito Asada; Shin-Ichiro Kawazu; Darrick Carter; Noboru Inoue
Journal:  Parasitol Int       Date:  2011-09-14       Impact factor: 2.230

3.  Calcium-dependent proteolytic activity of a cysteine protease caldonopain is detected during Leishmania infection.

Authors:  Runu Dey; Jharna Bhattacharya; Salil C Datta
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses.

Authors:  Paulo Henrique da Costa Pinheiro; Suzana de Souza Dias; Kelsen Dantas Eulálio; Ivete L Mendonça; Simone Katz; Clara Lúcia Barbiéri
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  The efficacy of L. (L.) chagasi excreted-secreted antigens (ESAs) for visceral leishmaniasis diagnosis is due to low levels of cross-reactivity.

Authors:  Viviana Pinedo-Cancino; Norival Kesper; Clara Lúcia Barbiéri; José Angelo Lauletta Lindoso; Eufrosina Setsu Umezawa
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

6.  Use of Recombinant Antigens for Sensitive Serodiagnosis of American Tegumentary Leishmaniasis Caused by Different Leishmania Species.

Authors:  Camila Massae Sato; Maria Carmen Arroyo Sanchez; Beatriz Julieta Celeste; Malcolm S Duthie; Jeffrey Guderian; Steven G Reed; Maria Edileuza Felinto de Brito; Marliane Batista Campos; Helia Valeria de Souza Encarnação; Jorge Guerra; Tirza Gabrielle Ramos de Mesquita; Suzana Kanawati Pinheiro; Rajendranath Ramasawmy; Fernando Tobias Silveira; Marina de Assis Souza; Hiro Goto
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

7.  Leptomonas seymouri and Crithidia fasciculata exoantigens can discriminate human cases of visceral leishmaniasis from American tegumentary leishmaniasis ones.

Authors:  Norival Kesper; Marta Maria G Teixeira; José Angelo L Lindoso; Clara Lúcia Barbieri; Eufrosina Setsu Umezawa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

8.  Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.

Authors:  Ana Paula Souza; Manuel Soto; Jackson M L Costa; Viviane S Boaventura; Camila I de Oliveira; Juqueline R Cristal; Manoel Barral-Netto; Aldina Barral
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

9.  Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.

Authors:  Josie Haydée Lima Ferreira; Lucilene Dos Santos Silva; Ieda Maria Longo-Maugéri; Simone Katz; Clara Lúcia Barbiéri
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

10.  Immunoproteomic Identification and Characterization of Leishmania Membrane Proteins as Non-Invasive Diagnostic Candidates for Clinical Visceral Leishmaniasis.

Authors:  Sarfaraz Ahmad Ejazi; Anirban Bhattacharyya; Somsubhra Thakur Choudhury; Sneha Ghosh; Abdus Sabur; Krishna Pandey; Vidya Nand Ravi Das; Pradeep Das; Mehebubar Rahaman; Rama Prosad Goswami; Nahid Ali
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.